arrow
J

Julian Buchrieser

Centre National de la Recherche Scientifique
H指数:30
被引数:7,036

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1

温度依赖性复制和对人冠状病毒HKU1先天免疫的敏感性

2026-07-270
OAAI
Structural basis of poxvirus fusion regulation and anti-A16/G9 antibody-mediated neutralization and protection

痘病毒融合调控及抗A16/G9抗体介导的中和与保护的结构基础

Cell
IF42.5
2025-08-260
OAAI
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model

表达融合前稳定的SARS-CoV-2刺突蛋白的麻疹载体疫苗候选物进入I/II期临床试验: 临床前小鼠模型中的候选物选择

2024-05-141
PRE
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
2024-03-1345
OAAI
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
2024-01-233
OA
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies

接受单克隆抗体的患者血清中和SARS-CoV-2 Omicron BA.2,BA.4和BA.5的纵向分析

2022-12-0145
OAAI
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants

尖峰稳定的D614G突变与S1/S2切割位点突变相互作用,以促进SARS-CoV-2变体的感染潜力

2022-10-1212
OAAI
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2

SARS-CoV-2三角洲亚系AY.4.2的融合力和中和敏感性

2022-03-0111
OAAI
Low CCR5 expression protects HIV-specific CD4+T cells of elite controllers from viral entry

低CCR5表达保护精英控制者的HIV特异性CD4 T细胞免受病毒进入

2022-01-2632
OAAI
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Nature
IF48.5
2021-12-230
PRE
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
2021-03-26543
PREAI